Does early intensive, goal-directed vasodilation improve outcomes in acute heart failure patients? It’s the question that the trial GALACTIC seeks to answer to. We met the trial’s Principal Investigator, Christian Eugen Mueller, Director of the Cardiovascular Research Institute at the Department of Cardiology of the University Hospital of Basel, at the ESC 2019 congress in Paris.
Early intensive and goal-directed vasodilation in acute heart failure
Dai congressiIntervisteCARDIOINFO@ESC2019
Scelti dall'editore
- Heart failure of tomorrow. Interview with Milton Packer
Milton Packer Baylor Heart and Vascular Institute Baylor University Medical Center, Dallas
- Heart Failure Congress 2016: a Firenze il punto sullo scompenso cardiaco
Approda per la seconda volta in Italia l’Heart Failure Congress, dove i maggiori esperti a…